Yes Bedger, selling now (below the entitlement price) was/is defo a bit premature.
Understand revenue capture has been poor and SP is not reflecting positivity. However, noting current momentum from partnerships and a company only listed around the on-set of COVID (with a recent push for commercialization) - I really see it oversold.
Next 4 quarters are crucial that being said. Management would really need to pull their socks up.
Ann: Non-Renounceable Entitlement Offer - Results, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.002(5.00%) |
Mkt cap ! $4.853M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 4.5¢ | 3.8¢ | $78.97K | 1.954M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 322736 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 1445877 | 7 |
View Market Depth
| Last trade - 12.53pm 27/09/2024 (20 minute delay) ? |
| OSX (ASX) Chart |